Drug Type Small molecule drug |
Synonyms BPP-1001 |
Target |
Action inhibitors |
Mechanism FLAP inhibitors(5-lipoxygenase activating protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Discovery | United States | - | |
Neuritis | Discovery | United States | - |